Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1995 Jun;54(6):501–528. doi: 10.1136/ard.54.6.501-a

2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

PMCID: PMC1009911  PMID: 7632095

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aicher W. K., Heer A. H., Trabandt A., Bridges S. L., Jr, Schroeder H. W., Jr, Stransky G., Gay R. E., Eibel H., Peter H. H., Siebenlist U. Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol. 1994 Jun 15;152(12):5940–5948. [PubMed] [Google Scholar]
  2. Allard S. A., Bayliss M. T., Maini R. N. The synovium-cartilage junction of the normal human knee. Implications for joint destruction and repair. Arthritis Rheum. 1990 Aug;33(8):1170–1179. doi: 10.1002/art.1780330818. [DOI] [PubMed] [Google Scholar]
  3. Allard S. A., Muirden K. D., Maini R. N. Correlation of histopathological features of pannus with patterns of damage in different joints in rheumatoid arthritis. Ann Rheum Dis. 1991 May;50(5):278–283. doi: 10.1136/ard.50.5.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ambrosio G., Zweier J. L., Duilio C., Kuppusamy P., Santoro G., Elia P. P., Tritto I., Cirillo P., Condorelli M., Chiariello M. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem. 1993 Sep 5;268(25):18532–18541. [PubMed] [Google Scholar]
  5. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129–157. doi: 10.1016/0304-419x(91)90011-9. [DOI] [PubMed] [Google Scholar]
  6. Baker D. G., Dayer J. M., Roelke M., Schumacher H. R., Krane S. M. Rheumatoid synovial cell morphologic changes induced by a mononuclear cell factor in culture. Arthritis Rheum. 1983 Jan;26(1):8–14. doi: 10.1002/art.1780260102. [DOI] [PubMed] [Google Scholar]
  7. Bashir S., Harris G., Denman M. A., Blake D. R., Winyard P. G. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis. 1993 Sep;52(9):659–666. doi: 10.1136/ard.52.9.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bates E. J., Johnson C. C., Lowther D. A. Inhibition of proteoglycan synthesis by hydrogen peroxide in cultured bovine articular cartilage. Biochim Biophys Acta. 1985 Feb 15;838(2):221–228. doi: 10.1016/0304-4165(85)90082-0. [DOI] [PubMed] [Google Scholar]
  9. Bax B. E., Alam A. S., Banerji B., Bax C. M., Bevis P. J., Stevens C. R., Moonga B. S., Blake D. R., Zaidi M. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun. 1992 Mar 31;183(3):1153–1158. doi: 10.1016/s0006-291x(05)80311-0. [DOI] [PubMed] [Google Scholar]
  10. Beckman J. S., Chen J., Ischiropoulos H., Crow J. P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 1994;233:229–240. doi: 10.1016/s0076-6879(94)33026-3. [DOI] [PubMed] [Google Scholar]
  11. Beutler A., Rothfuss S., Clayburne G., Sieck M., Schumacher H. R., Jr Calcium pyrophosphate dihydrate crystal deposition in synovium. Relationship to collagen fibers and chondrometaplasia. Arthritis Rheum. 1993 May;36(5):704–715. doi: 10.1002/art.1780360520. [DOI] [PubMed] [Google Scholar]
  12. Biemond P., Swaak A. J., Koster J. F. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum. 1984 Jul;27(7):760–765. doi: 10.1002/art.1780270706. [DOI] [PubMed] [Google Scholar]
  13. Biemond P., Swaak A. J., van Eijk H. G., Koster J. F. Intraarticular ferritin-bound iron in rheumatoid arthritis. A factor that increases oxygen free radical-induced tissue destruction. Arthritis Rheum. 1986 Oct;29(10):1187–1193. doi: 10.1002/art.1780291002. [DOI] [PubMed] [Google Scholar]
  14. Blake D. R., Hall N. D., Treby D. A., Halliwell B., Gutteridge J. M. Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci (Lond) 1981 Oct;61(4):483–486. doi: 10.1042/cs0610483. [DOI] [PubMed] [Google Scholar]
  15. Bosma G. C., Custer R. P., Bosma M. J. A severe combined immunodeficiency mutation in the mouse. Nature. 1983 Feb 10;301(5900):527–530. doi: 10.1038/301527a0. [DOI] [PubMed] [Google Scholar]
  16. Brenner D. A., O'Hara M., Angel P., Chojkier M., Karin M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 1989 Feb 16;337(6208):661–663. doi: 10.1038/337661a0. [DOI] [PubMed] [Google Scholar]
  17. Brinckerhoff C. E., Harris E. D., Jr Survival of rheumatoid synovium implanted into nude mice. Am J Pathol. 1981 Jun;103(3):411–418. [PMC free article] [PubMed] [Google Scholar]
  18. Burton G. W., Traber M. G. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr. 1990;10:357–382. doi: 10.1146/annurev.nu.10.070190.002041. [DOI] [PubMed] [Google Scholar]
  19. Candeias L. P., Patel K. B., Stratford M. R., Wardman P. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett. 1993 Oct 25;333(1-2):151–153. doi: 10.1016/0014-5793(93)80394-a. [DOI] [PubMed] [Google Scholar]
  20. Capon D. J., Chamow S. M., Mordenti J., Marsters S. A., Gregory T., Mitsuya H., Byrn R. A., Lucas C., Wurm F. M., Groopman J. E. Designing CD4 immunoadhesins for AIDS therapy. Nature. 1989 Feb 9;337(6207):525–531. doi: 10.1038/337525a0. [DOI] [PubMed] [Google Scholar]
  21. Carreras M. C., Pargament G. A., Catz S. D., Poderoso J. J., Boveris A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett. 1994 Mar 14;341(1):65–68. doi: 10.1016/0014-5793(94)80241-6. [DOI] [PubMed] [Google Scholar]
  22. Case J. P., Lafyatis R., Remmers E. F., Kumkumian G. K., Wilder R. L. Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes. Am J Pathol. 1989 Dec;135(6):1055–1064. [PMC free article] [PubMed] [Google Scholar]
  23. Chapman M. L., Rubin B. R., Gracy R. W. Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J Rheumatol. 1989 Jan;16(1):15–18. [PubMed] [Google Scholar]
  24. Chidwick K., Winyard P. G., Zhang Z., Farrell A. J., Blake D. R. Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis. 1991 Dec;50(12):915–916. doi: 10.1136/ard.50.12.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Chu C. Q., Field M., Abney E., Zheng R. Q., Allard S., Feldmann M., Maini R. N. Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction. Clin Exp Immunol. 1991 Dec;86(3):380–386. doi: 10.1111/j.1365-2249.1991.tb02941.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Chu C. Q., Field M., Allard S., Abney E., Feldmann M., Maini R. N. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol. 1992 Oct;31(10):653–661. doi: 10.1093/rheumatology/31.10.653. [DOI] [PubMed] [Google Scholar]
  27. Chu C. Q., Field M., Feldmann M., Maini R. N. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991 Sep;34(9):1125–1132. doi: 10.1002/art.1780340908. [DOI] [PubMed] [Google Scholar]
  28. Chu C. Q., Field M., Feldmann M., Maini R. N. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991 Sep;34(9):1125–1132. doi: 10.1002/art.1780340908. [DOI] [PubMed] [Google Scholar]
  29. Curnutte J. T., Babior B. M. Chronic granulomatous disease. Adv Hum Genet. 1987;16:229–297. doi: 10.1007/978-1-4757-0620-8_4. [DOI] [PubMed] [Google Scholar]
  30. Davies J. M., Horwitz D. A., Davies K. J. Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Free Radic Biol Med. 1993 Dec;15(6):637–643. doi: 10.1016/0891-5849(93)90167-s. [DOI] [PubMed] [Google Scholar]
  31. Dayer J. M., Graham R., Russell G., Krane S. M. Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science. 1977 Jan 14;195(4274):181–183. doi: 10.1126/science.188134. [DOI] [PubMed] [Google Scholar]
  32. Deleuran B. W., Chu C. Q., Field M., Brennan F. M., Katsikis P., Feldmann M., Maini R. N. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol. 1992 Dec;31(12):801–809. doi: 10.1093/rheumatology/31.12.801. [DOI] [PubMed] [Google Scholar]
  33. Deleuran B. W., Chu C. Q., Field M., Brennan F. M., Mitchell T., Feldmann M., Maini R. N. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum. 1992 Oct;35(10):1170–1178. doi: 10.1002/art.1780351009. [DOI] [PubMed] [Google Scholar]
  34. Dougados M., Combe B., Beveridge T., Bourdeix I., Lallemand A., Amor B., Sany J. IX 207-887 in rheumatoid arthritis. A double-blind placebo-controlled study. Arthritis Rheum. 1992 Sep;35(9):999–1006. doi: 10.1002/art.1780350904. [DOI] [PubMed] [Google Scholar]
  35. Dowling E. J., Chander C. L., Claxson A. W., Lillie C., Blake D. R. Assessment of a human recombinant manganese superoxide dismutase in models of inflammation. Free Radic Res Commun. 1993;18(5):291–298. doi: 10.3109/10715769309147496. [DOI] [PubMed] [Google Scholar]
  36. Duke O., Panayi G. S., Janossy G., Poulter L. W. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol. 1982 Jul;49(1):22–30. [PMC free article] [PubMed] [Google Scholar]
  37. Dupuy C., Virion A., Ohayon R., Kaniewski J., Dème D., Pommier J. Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane. J Biol Chem. 1991 Feb 25;266(6):3739–3743. [PubMed] [Google Scholar]
  38. Edwards J. C., Willoughby D. A. Demonstration of bone marrow derived cells in synovial lining by means of giant intracellular granules as genetic markers. Ann Rheum Dis. 1982 Apr;41(2):177–182. doi: 10.1136/ard.41.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Katsikis P., Brennan F. M., Walker J., Bijl H., Ghrayeb J. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993 Dec;36(12):1681–1690. doi: 10.1002/art.1780361206. [DOI] [PubMed] [Google Scholar]
  40. Evans P. J., Akanmu D., Halliwell B. Promotion of oxidative damage to arachidonic acid and alpha 1-antiproteinase by anti-inflammatory drugs in the presence of the haem proteins myoglobin and cytochrome C. Biochem Pharmacol. 1994 Dec 16;48(12):2173–2179. doi: 10.1016/0006-2952(94)90351-4. [DOI] [PubMed] [Google Scholar]
  41. Fairburn K., Grootveld M., Ward R. J., Abiuka C., Kus M., Williams R. B., Winyard P. G., Blake D. R. Alpha-tocopherol, lipids and lipoproteins in knee-joint synovial fluid and serum from patients with inflammatory joint disease. Clin Sci (Lond) 1992 Dec;83(6):657–664. doi: 10.1042/cs0830657. [DOI] [PubMed] [Google Scholar]
  42. Farrell A. J., Blake D. R., Palmer R. M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis. 1992 Nov;51(11):1219–1222. doi: 10.1136/ard.51.11.1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Fassbender H. G. Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res. 1983 Mar;3(2):141–155. doi: 10.1016/s0174-173x(83)80040-5. [DOI] [PubMed] [Google Scholar]
  44. Field M., Chu C., Feldmann M., Maini R. N. Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis. Rheumatol Int. 1991;11(2):45–50. doi: 10.1007/BF00291144. [DOI] [PubMed] [Google Scholar]
  45. Firestein G. S., Paine M. M., Boyle D. L. Mechanisms of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression. Arthritis Rheum. 1994 Feb;37(2):193–200. doi: 10.1002/art.1780370207. [DOI] [PubMed] [Google Scholar]
  46. Firestein G. S., Zvaifler N. J. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 1990 Jun;33(6):768–773. doi: 10.1002/art.1780330602. [DOI] [PubMed] [Google Scholar]
  47. FitzGerald O., Soden M., Yanni G., Robinson R., Bresnihan B. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis. 1991 Nov;50(11):792–796. doi: 10.1136/ard.50.11.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Fox D. A., Millard J. A., Kan L., Zeldes W. S., Davis W., Higgs J., Emmrich F., Kinne R. W. Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest. 1990 Oct;86(4):1124–1136. doi: 10.1172/JCI114817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Fry D. W., Kraker A. J., McMichael A., Ambroso L. A., Nelson J. M., Leopold W. R., Connors R. W., Bridges A. J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science. 1994 Aug 19;265(5175):1093–1095. doi: 10.1126/science.8066447. [DOI] [PubMed] [Google Scholar]
  50. Garrett I. R., Boyce B. F., Oreffo R. O., Bonewald L., Poser J., Mundy G. R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest. 1990 Mar;85(3):632–639. doi: 10.1172/JCI114485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Gearing A. J., Beckett P., Christodoulou M., Churchill M., Clements J., Davidson A. H., Drummond A. H., Galloway W. A., Gilbert R., Gordon J. L. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature. 1994 Aug 18;370(6490):555–557. doi: 10.1038/370555a0. [DOI] [PubMed] [Google Scholar]
  52. Geiler G., Emmrich J. Veränderungen an der Synovialmembran bei Frühfällen der rhematoiden Arthritis. I. Histologische Untersuchungen. Z Rheumatol. 1980 Jan-Feb;39(1-2):33–45. [PubMed] [Google Scholar]
  53. Gerdes J., Lemke H., Baisch H., Wacker H. H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984 Oct;133(4):1710–1715. [PubMed] [Google Scholar]
  54. Gerritsen M. E., Kelley K. A., Ligon G., Perry C. A., Shen C. P., Szczepanski A., Carley W. W. Regulation of the expression of intercellular adhesion molecule 1 in cultured human endothelial cells derived from rheumatoid synovium. Arthritis Rheum. 1993 May;36(5):593–602. doi: 10.1002/art.1780360504. [DOI] [PubMed] [Google Scholar]
  55. Grisham M. B., Ware K., Marshall S., Yamada T., Sandhu I. S. Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects. Dig Dis Sci. 1992 Sep;37(9):1383–1389. doi: 10.1007/BF01296008. [DOI] [PubMed] [Google Scholar]
  56. Grootveld M., Halliwell B. Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids. Biochem J. 1986 Jul 15;237(2):499–504. doi: 10.1042/bj2370499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Grootveld M., Halliwell B. Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo? Biochem J. 1987 May 1;243(3):803–808. doi: 10.1042/bj2430803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Grootveld M., Henderson E. B., Farrell A., Blake D. R., Parkes H. G., Haycock P. Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J. 1991 Jan 15;273(Pt 2):459–467. doi: 10.1042/bj2730459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Gutteridge J. M. Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin and lactoferrin. Biochem J. 1987 Jul 15;245(2):415–421. doi: 10.1042/bj2450415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Gutteridge J. M. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 1986 Jun 9;201(2):291–295. doi: 10.1016/0014-5793(86)80626-3. [DOI] [PubMed] [Google Scholar]
  61. Gutteridge J. M., Rowley D. A., Griffiths E., Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci (Lond) 1985 Apr;68(4):463–467. doi: 10.1042/cs0680463. [DOI] [PubMed] [Google Scholar]
  62. Gutteridge J. M., Rowley D. A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids. Biochem J. 1982 Sep 15;206(3):605–609. doi: 10.1042/bj2060605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Halliwell B. Drug antioxidant effects. A basis for drug selection? Drugs. 1991 Oct;42(4):569–605. doi: 10.2165/00003495-199142040-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Halliwell B., Evans P. J., Kaur H., Chirico S. Drug derived radicals: mediators of the side effects of anti-inflammatory drugs? Ann Rheum Dis. 1992 Nov;51(11):1261–1263. doi: 10.1136/ard.51.11.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Halliwell B., Gutteridge J. M., Cross C. E. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med. 1992 Jun;119(6):598–620. [PubMed] [Google Scholar]
  66. Halliwell B., Gutteridge J. M. The antioxidants of human extracellular fluids. Arch Biochem Biophys. 1990 Jul;280(1):1–8. doi: 10.1016/0003-9861(90)90510-6. [DOI] [PubMed] [Google Scholar]
  67. Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Its role in degradation of hyaluronic acid by a superoxide-generating system. FEBS Lett. 1978 Dec 15;96(2):238–242. doi: 10.1016/0014-5793(78)80409-8. [DOI] [PubMed] [Google Scholar]
  68. Halliwell B., Wasil M., Grootveld M. Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid. Implications for antioxidant protection in the inflamed rheumatoid joint. FEBS Lett. 1987 Mar 9;213(1):15–17. doi: 10.1016/0014-5793(87)81456-4. [DOI] [PubMed] [Google Scholar]
  69. Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P., Thompson R. C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990 Jan 25;343(6256):336–340. doi: 10.1038/343336a0. [DOI] [PubMed] [Google Scholar]
  70. Hasselbacher P., Schumacher H. R. Immunoglobulin in tophi and on the surface of monosodium urate crystals. Arthritis Rheum. 1978 Apr;21(3):353–361. doi: 10.1002/art.1780210311. [DOI] [PubMed] [Google Scholar]
  71. Henderson B., Blake S. Therapeutic potential of cytokine manipulation. Trends Pharmacol Sci. 1992 Apr;13(4):145–152. doi: 10.1016/0165-6147(92)90052-8. [DOI] [PubMed] [Google Scholar]
  72. Henderson B., Hardingham T., Blake S., Lewthwaite J. Experimental arthritis models in the study of the mechanisms of articular cartilage loss in rheumatoid arthritis. Agents Actions Suppl. 1993;39:15–26. doi: 10.1007/978-3-0348-7442-7_2. [DOI] [PubMed] [Google Scholar]
  73. Henderson B., Poole S. Modulation of cytokine function: therapeutic applications. Adv Pharmacol. 1994;25:53–115. doi: 10.1016/s1054-3589(08)60430-5. [DOI] [PubMed] [Google Scholar]
  74. Henderson E. B., Grootveld M., Farrell A., Smith E. C., Thompson P. W., Blake D. R. A pathological role for damaged hyaluronan in synovitis. Ann Rheum Dis. 1991 Mar;50(3):196–200. doi: 10.1136/ard.50.3.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Hoffstein S. T., Gennaro D. E., Meunier P. C. Cytochemical demonstration of constitutive H2O2 production by macrophages in synovial tissue from rats with adjuvant arthritis. Am J Pathol. 1988 Jan;130(1):120–125. [PMC free article] [PubMed] [Google Scholar]
  76. Hopkins S. J., Humphreys M., Jayson M. I. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol. 1988 Jun;72(3):422–427. [PMC free article] [PubMed] [Google Scholar]
  77. Humad S., Zarling E., Clapper M., Skosey J. L. Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. Free Radic Res Commun. 1988;5(2):101–106. doi: 10.3109/10715768809066917. [DOI] [PubMed] [Google Scholar]
  78. Ingelman-Sundberg M., Kaur H., Terelius Y., Persson J. O., Halliwell B. Hydroxylation of salicylate by microsomal fractions and cytochrome P-450. Lack of production of 2,3-dihydroxybenzoate unless hydroxyl radical formation is permitted. Biochem J. 1991 Jun 15;276(Pt 3):753–757. doi: 10.1042/bj2760753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Janusz M. J., Hare M. Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines. A model of metalloproteinase-mediated connective tissue degradation. J Immunol. 1993 Mar 1;150(5):1922–1931. [PubMed] [Google Scholar]
  80. Jasin H. E. Oxidative cross-linking of immune complexes by human polymorphonuclear leukocytes. J Clin Invest. 1988 Jan;81(1):6–15. doi: 10.1172/JCI113310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. KULKA J. P., BOCKING D., ROPES M. W., BAUER W. Early joint lesions of rheumatoid arthritis; report of eight cases, with knee biopsies of lesions of less than one year's duration. AMA Arch Pathol. 1955 Feb;59(2):129–150. [PubMed] [Google Scholar]
  82. Kaur H., Fagerheim I., Grootveld M., Puppo A., Halliwell B. Aromatic hydroxylation of phenylalanine as an assay for hydroxyl radicals: application to activated human neutrophils and to the heme protein leghemoglobin. Anal Biochem. 1988 Aug 1;172(2):360–367. doi: 10.1016/0003-2697(88)90456-3. [DOI] [PubMed] [Google Scholar]
  83. Kaur H., Halliwell B. Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. Chem Biol Interact. 1990;73(2-3):235–247. doi: 10.1016/0009-2797(90)90006-9. [DOI] [PubMed] [Google Scholar]
  84. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 1994 Aug 15;350(1):9–12. doi: 10.1016/0014-5793(94)00722-5. [DOI] [PubMed] [Google Scholar]
  85. Kawasaki N., Tanimoto T., Tanaka A., Hayakawa T., Miyasaka N. Determination of non-protein-bound iron in human synovial fluid by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl. 1994 Jun 17;656(2):436–440. doi: 10.1016/0378-4347(94)00135-9. [DOI] [PubMed] [Google Scholar]
  86. Key L. L., Jr, Ries W. L., Glasscock H., Rodriguiz R., Jaffe H. Osteoclastic superoxide generation: taking control of bone resorption using modulators of superoxide concentrations. Int J Tissue React. 1992;14(6):295–298. [PubMed] [Google Scholar]
  87. Knight A. D., Levick J. R. The density and distribution of capillaries around a synovial cavity. Q J Exp Physiol. 1983 Oct;68(4):629–644. doi: 10.1113/expphysiol.1983.sp002753. [DOI] [PubMed] [Google Scholar]
  88. Koch A. E., Burrows J. C., Haines G. K., Carlos T. M., Harlan J. M., Leibovich S. J. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest. 1991 Mar;64(3):313–320. [PubMed] [Google Scholar]
  89. Konttinen Y. T., Nykänen P., Nordström D., Saari H., Sandelin J., Santavirta S., Kouri T. DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J Rheumatol. 1989 Mar;16(3):339–345. [PubMed] [Google Scholar]
  90. Kuroki Y., Shiozawa S., Yoshihara R., Hotta H. The contribution of human c-fos DNA to cultured synovial cells: a transfection study. J Rheumatol. 1993 Mar;20(3):422–428. [PubMed] [Google Scholar]
  91. Kurosaka M., Ziff M. Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med. 1983 Oct 1;158(4):1191–1210. doi: 10.1084/jem.158.4.1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Lafyatis R., Thompson N. L., Remmers E. F., Flanders K. C., Roche N. S., Kim S. J., Case J. P., Sporn M. B., Roberts A. B., Wilder R. L. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol. 1989 Aug 15;143(4):1142–1148. [PubMed] [Google Scholar]
  93. Lalor P. A., Mapp P. I., Hall P. A., Revell P. A. Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int. 1987;7(5):183–186. doi: 10.1007/BF00541375. [DOI] [PubMed] [Google Scholar]
  94. Lalor P. A., Mapp P. I., Hall P. A., Revell P. A. Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int. 1987;7(5):183–186. doi: 10.1007/BF00541375. [DOI] [PubMed] [Google Scholar]
  95. Lauhio A., Leirisalo-Repo M., Lähdevirta J., Saikku P., Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991 Jan;34(1):6–14. doi: 10.1002/art.1780340103. [DOI] [PubMed] [Google Scholar]
  96. Lewthwaite J., Blake S. M., Hardingham T. E., Warden P. J., Henderson B. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit. J Rheumatol. 1994 Mar;21(3):467–472. [PubMed] [Google Scholar]
  97. Lindblad S., Klareskog L., Hedfors E., Forsum U., Sundström C. Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum. 1983 Nov;26(11):1321–1332. doi: 10.1002/art.1780261104. [DOI] [PubMed] [Google Scholar]
  98. Lindblad S., Klareskog L., Hedfors E., Forsum U., Sundström C. Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum. 1983 Nov;26(11):1321–1332. doi: 10.1002/art.1780261104. [DOI] [PubMed] [Google Scholar]
  99. Liu J. FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. Trends Pharmacol Sci. 1993 May;14(5):182–188. doi: 10.1016/0165-6147(93)90206-y. [DOI] [PubMed] [Google Scholar]
  100. Lohmander L. S., Neame P. J., Sandy J. D. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 1993 Sep;36(9):1214–1222. doi: 10.1002/art.1780360906. [DOI] [PubMed] [Google Scholar]
  101. Loose L. D., Sipe J. D., Kirby D. S., Kraska A. R., Weiner E. S., Shanahan W. R., Leeming M. R., Farrow P., Stack C. B., Ting N. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug. Br J Rheumatol. 1993 Jun;32 (Suppl 3):19–25. doi: 10.1093/rheumatology/32.suppl_3.19. [DOI] [PubMed] [Google Scholar]
  102. Lunec J., Blake D. R., McCleary S. J., Brailsford S., Bacon P. A. Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest. 1985 Dec;76(6):2084–2090. doi: 10.1172/JCI112212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Lunec J., Herbert K., Blount S., Griffiths H. R., Emery P. 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett. 1994 Jul 11;348(2):131–138. doi: 10.1016/0014-5793(94)00583-4. [DOI] [PubMed] [Google Scholar]
  104. MacIntyre I., Zaidi M., Alam A. S., Datta H. K., Moonga B. S., Lidbury P. S., Hecker M., Vane J. R. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2936–2940. doi: 10.1073/pnas.88.7.2936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. MacNaul K. L., Chartrain N., Lark M., Tocci M. J., Hutchinson N. I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem. 1990 Oct 5;265(28):17238–17245. [PubMed] [Google Scholar]
  106. McCachren S. S. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 1991 Sep;34(9):1085–1093. doi: 10.1002/art.1780340904. [DOI] [PubMed] [Google Scholar]
  107. McCachren S. S., Haynes B. F., Niedel J. E. Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry. J Clin Immunol. 1990 Jan;10(1):19–27. doi: 10.1007/BF00917494. [DOI] [PubMed] [Google Scholar]
  108. McCord J. M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974 Aug 9;185(4150):529–531. doi: 10.1126/science.185.4150.529. [DOI] [PubMed] [Google Scholar]
  109. McGeehan G. M., Becherer J. D., Bast R. C., Jr, Boyer C. M., Champion B., Connolly K. M., Conway J. G., Furdon P., Karp S., Kidao S. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature. 1994 Aug 18;370(6490):558–561. doi: 10.1038/370558a0. [DOI] [PubMed] [Google Scholar]
  110. McLaren G. D., Muir W. A., Kellermeyer R. W. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci. 1983;19(3):205–266. doi: 10.3109/10408368309165764. [DOI] [PubMed] [Google Scholar]
  111. Means R. T., Jr, Krantz S. B. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood. 1992 Oct 1;80(7):1639–1647. [PubMed] [Google Scholar]
  112. Meier B., Radeke H. H., Selle S., Raspe H. H., Sies H., Resch K., Habermehl G. G. Human fibroblasts release reactive oxygen species in response to treatment with synovial fluids from patients suffering from arthritis. Free Radic Res Commun. 1990;8(3):149–160. doi: 10.3109/10715769009087988. [DOI] [PubMed] [Google Scholar]
  113. Michaelis J., Vissers M. C., Winterbourn C. C. Different effects of hypochlorous acid on human neutrophil metalloproteinases: activation of collagenase and inactivation of collagenase and gelatinase. Arch Biochem Biophys. 1992 Feb 1;292(2):555–562. doi: 10.1016/0003-9861(92)90030-z. [DOI] [PubMed] [Google Scholar]
  114. Miesel R., Zuber M. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. Inflammation. 1993 Oct;17(5):551–561. doi: 10.1007/BF00914193. [DOI] [PubMed] [Google Scholar]
  115. Mohler K. M., Sleath P. R., Fitzner J. N., Cerretti D. P., Alderson M., Kerwar S. S., Torrance D. S., Otten-Evans C., Greenstreet T., Weerawarna K. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 1994 Jul 21;370(6486):218–220. doi: 10.1038/370218a0. [DOI] [PubMed] [Google Scholar]
  116. Mohr W., Hummler N., Pelster B., Wessinghage D. Proliferation of pannus tissue cells in rheumatoid arthritis. Rheumatol Int. 1986;6(3):127–132. doi: 10.1007/BF00270349. [DOI] [PubMed] [Google Scholar]
  117. Muller D. P., Goss-Sampson M. A. Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. Crit Rev Neurobiol. 1990;5(3):239–263. [PubMed] [Google Scholar]
  118. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10045–10048. doi: 10.1073/pnas.88.22.10045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science. 1994 May 27;264(5163):1319–1322. doi: 10.1126/science.8191285. [DOI] [PubMed] [Google Scholar]
  120. Olczyk K. Age-related changes in proteoglycans of human intervertebral discs. Z Rheumatol. 1994 Jan-Feb;53(1):19–25. [PubMed] [Google Scholar]
  121. Olds L. C., Miller J. J., 3rd C3 activation products correlate with antibodies to lipid A in pauciarticular juvenile arthritis. Arthritis Rheum. 1990 Apr;33(4):520–524. doi: 10.1002/art.1780330409. [DOI] [PubMed] [Google Scholar]
  122. Orrenius S., McConkey D. J., Bellomo G., Nicotera P. Role of Ca2+ in toxic cell killing. Trends Pharmacol Sci. 1989 Jul;10(7):281–285. doi: 10.1016/0165-6147(89)90029-1. [DOI] [PubMed] [Google Scholar]
  123. Ortiz-Bravo E., Sieck M. S., Schumacher H. R., Jr Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum. 1993 Sep;36(9):1274–1285. doi: 10.1002/art.1780360912. [DOI] [PubMed] [Google Scholar]
  124. Palmer R. M., Hickery M. S., Charles I. G., Moncada S., Bayliss M. T. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun. 1993 May 28;193(1):398–405. doi: 10.1006/bbrc.1993.1637. [DOI] [PubMed] [Google Scholar]
  125. Pettipher E. R., Higgs G. A., Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8749–8753. doi: 10.1073/pnas.83.22.8749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Phillips M., Greenberg J., Sabas M. Alveolar gradient of pentane in normal human breath. Free Radic Res. 1994 May;20(5):333–337. doi: 10.3109/10715769409145633. [DOI] [PubMed] [Google Scholar]
  127. Piguet P. F., Vesin C., Grau G. E., Thompson R. C. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine. 1993 Jan;5(1):57–61. doi: 10.1016/1043-4666(93)90024-y. [DOI] [PubMed] [Google Scholar]
  128. Qu Z., Garcia C. H., O'Rourke L. M., Planck S. R., Kohli M., Rosenbaum J. T. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 1994 Feb;37(2):212–220. doi: 10.1002/art.1780370210. [DOI] [PubMed] [Google Scholar]
  129. Qu Z., Garcia C. H., O'Rourke L. M., Planck S. R., Kohli M., Rosenbaum J. T. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 1994 Feb;37(2):212–220. doi: 10.1002/art.1780370210. [DOI] [PubMed] [Google Scholar]
  130. Rathakrishnan C., Tiku K., Raghavan A., Tiku M. L. Release of oxygen radicals by articular chondrocytes: a study of luminol-dependent chemiluminescence and hydrogen peroxide secretion. J Bone Miner Res. 1992 Oct;7(10):1139–1148. doi: 10.1002/jbmr.5650071005. [DOI] [PubMed] [Google Scholar]
  131. Remmers E. F., Sano H., Wilder R. L. Platelet-derived growth factors and heparin-binding (fibroblast) growth factors in the synovial tissue pathology of rheumatoid arthritis. Semin Arthritis Rheum. 1991 Dec;21(3):191–199. doi: 10.1016/0049-0172(91)90009-o. [DOI] [PubMed] [Google Scholar]
  132. Rich S. A., Marko M., Gibbons W. E. Localization of interferon-induced lupus inclusions demonstrated by computer image reconstruction of monensin-treated Daudi cells. J Struct Biol. 1992 Jan-Feb;108(1):25–34. doi: 10.1016/1047-8477(92)90004-t. [DOI] [PubMed] [Google Scholar]
  133. Ritchlin C. T., Winchester R. J. Potential mechanisms for coordinate gene activation in the rheumatoid synoviocyte: implications and hypotheses. Springer Semin Immunopathol. 1989;11(3):219–234. doi: 10.1007/BF00197304. [DOI] [PubMed] [Google Scholar]
  134. Robinson J., Watson F., Bucknall R. C., Edwards S. W. Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease. Soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells. Biochem J. 1992 Sep 1;286(Pt 2):345–351. doi: 10.1042/bj2860345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Rodemann H. P., Müller G. A. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis. 1991 Jun;17(6):684–686. doi: 10.1016/s0272-6386(12)80352-0. [DOI] [PubMed] [Google Scholar]
  136. Rooney M., Whelan A., Feighery C., Bresnihan B. Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis. Arthritis Rheum. 1989 Apr;32(4):361–369. doi: 10.1002/anr.1780320402. [DOI] [PubMed] [Google Scholar]
  137. Rowley D., Gutteridge J. M., Blake D., Farr M., Halliwell B. Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci (Lond) 1984 Jun;66(6):691–695. doi: 10.1042/cs0660691. [DOI] [PubMed] [Google Scholar]
  138. Rubartelli A., Sitia R. Interleukin 1 beta and thioredoxin are secreted through a novel pathway of secretion. Biochem Soc Trans. 1991 Apr;19(2):255–259. doi: 10.1042/bst0190255. [DOI] [PubMed] [Google Scholar]
  139. Sack U., Kinne R. W., Marx T., Heppt P., Bender S., Emmrich F. Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int. 1993;13(2):45–51. doi: 10.1007/BF00307733. [DOI] [PubMed] [Google Scholar]
  140. Sack U., Kuhn H., Ermann J., Kinne R. W., Vogt S., Jungmichel D., Emmrich F. Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice. J Rheumatol. 1994 Jan;21(1):10–16. [PubMed] [Google Scholar]
  141. Sarafian T. A., Bredesen D. E. Is apoptosis mediated by reactive oxygen species? Free Radic Res. 1994 Jul;21(1):1–8. doi: 10.3109/10715769409056549. [DOI] [PubMed] [Google Scholar]
  142. Saragovi H. U., Fitzpatrick D., Raktabutr A., Nakanishi H., Kahn M., Greene M. I. Design and synthesis of a mimetic from an antibody complementarity-determining region. Science. 1991 Aug 16;253(5021):792–795. doi: 10.1126/science.1876837. [DOI] [PubMed] [Google Scholar]
  143. Schaible U. E., Gay S., Museteanu C., Kramer M. D., Zimmer G., Eichmann K., Museteanu U., Simon M. M. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol. 1990 Oct;137(4):811–820. [PMC free article] [PubMed] [Google Scholar]
  144. Schalkwijk J., van den Berg W. B., van de Putte L. B., Joosten L. A. An experimental model for hydrogen peroxide-induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues. Arthritis Rheum. 1986 Apr;29(4):532–538. doi: 10.1002/art.1780290411. [DOI] [PubMed] [Google Scholar]
  145. Schreck R., Albermann K., Baeuerle P. A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun. 1992;17(4):221–237. doi: 10.3109/10715769209079515. [DOI] [PubMed] [Google Scholar]
  146. Schulze-Osthoff K., Bakker A. C., Vanhaesebroeck B., Beyaert R., Jacob W. A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem. 1992 Mar 15;267(8):5317–5323. [PubMed] [Google Scholar]
  147. Schumacher H. R., Jr, Bautista B. B., Krauser R. E., Mathur A. K., Gall E. P. Histological appearance of the synovium in early rheumatoid arthritis. Semin Arthritis Rheum. 1994 Jun;23(6 Suppl 2):3–10. doi: 10.1016/0049-0172(94)90079-5. [DOI] [PubMed] [Google Scholar]
  148. Schumacher H. R., Jr Pathology of crystal deposition diseases. Rheum Dis Clin North Am. 1988 Aug;14(2):269–288. [PubMed] [Google Scholar]
  149. Schumacher H. R., Kitridou R. C. Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum. 1972 Sep-Oct;15(5):465–485. doi: 10.1002/art.1780150502. [DOI] [PubMed] [Google Scholar]
  150. Schumacher H. R., Kitridou R. C. Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum. 1972 Sep-Oct;15(5):465–485. doi: 10.1002/art.1780150502. [DOI] [PubMed] [Google Scholar]
  151. Selley M. L., Bourne D. J., Bartlett M. R., Tymms K. E., Brook A. S., Duffield A. M., Ardlie N. G. Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 1992 Apr;51(4):481–484. doi: 10.1136/ard.51.4.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Sewell K. L., Trentham D. E. Pathogenesis of rheumatoid arthritis. Lancet. 1993 Jan 30;341(8840):283–286. doi: 10.1016/0140-6736(93)92627-6. [DOI] [PubMed] [Google Scholar]
  153. Shiozawa S., Tanaka Y., Fujita T., Tokuhisa T. Destructive arthritis without lymphocyte infiltration in H2-c-fos transgenic mice. J Immunol. 1992 May 15;148(10):3100–3104. [PubMed] [Google Scholar]
  154. Smukler N. M., Schumacher H. R., Pascual E., Brown S., Ryan W. E., Sadeghian M. R. Synovial fat necrosis associated with ischemic pancreatic disease. Arthritis Rheum. 1979 May;22(5):547–553. doi: 10.1002/art.1780220517. [DOI] [PubMed] [Google Scholar]
  155. Soden M., Hassan J., Scott D. L., Hanly J. G., Moriarty M., Whelan A., Feighery C., Bresnihan B. Lymphoid irradiation in intractable rheumatoid arthritis. Long-term followup of patients treated with 750 rads or 2,000 rads. Arthritis Rheum. 1989 May;32(5):523–530. doi: 10.1002/anr.1780320503. [DOI] [PubMed] [Google Scholar]
  156. Soden M., Rooney M., Cullen A., Whelan A., Feighery C., Bresnihan B. Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis. Br J Rheumatol. 1989 Aug;28(4):287–292. doi: 10.1093/rheumatology/28.4.287. [DOI] [PubMed] [Google Scholar]
  157. Steere A. C., Duray P. H., Butcher E. C. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 1988 Apr;31(4):487–495. doi: 10.1002/art.1780310405. [DOI] [PubMed] [Google Scholar]
  158. Stevens C. R., Benboubetra M., Harrison R., Sahinoglu T., Smith E. C., Blake D. R. Localisation of xanthine oxidase to synovial endothelium. Ann Rheum Dis. 1991 Nov;50(11):760–762. doi: 10.1136/ard.50.11.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Stevens C. R., Mapp P. I., Revell P. A. A monoclonal antibody (Mab 67) marks type B synoviocytes. Rheumatol Int. 1990;10(3):103–106. doi: 10.1007/BF02274823. [DOI] [PubMed] [Google Scholar]
  160. Szekanecz Z., Haines G. K., Lin T. R., Harlow L. A., Goerdt S., Rayan G., Koch A. E. Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum. 1994 Feb;37(2):221–231. doi: 10.1002/art.1780370211. [DOI] [PubMed] [Google Scholar]
  161. Thorbecke G. J., Shah R., Leu C. H., Kuruvilla A. P., Hardison A. M., Palladino M. A. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7375–7379. doi: 10.1073/pnas.89.16.7375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Trabandt A., Aicher W. K., Gay R. E., Sukhatme V. P., Fassbender H. G., Gay S. Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheumatol Int. 1992;12(2):53–59. doi: 10.1007/BF00300977. [DOI] [PubMed] [Google Scholar]
  163. Trabandt A., Aicher W. K., Gay R. E., Sukhatme V. P., Nilson-Hamilton M., Hamilton R. T., McGhee J. R., Fassbender H. G., Gay S. Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. Matrix. 1990 Dec;10(6):349–361. doi: 10.1016/s0934-8832(11)80142-3. [DOI] [PubMed] [Google Scholar]
  164. Trabandt A., Gay R. E., Fassbender H. G., Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum. 1991 Nov;34(11):1444–1451. doi: 10.1002/art.1780341116. [DOI] [PubMed] [Google Scholar]
  165. Tröltzsch M. Farbdoppleruntersuchung bei Patienten mit einer rheumatoiden Arthritis und mit einer Sklerodermie. Z Rheumatol. 1994 Jan-Feb;53(1):2–6. [PubMed] [Google Scholar]
  166. Van der Vliet A., Smith D., O'Neill C. A., Kaur H., Darley-Usmar V., Cross C. E., Halliwell B. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J. 1994 Oct 1;303(Pt 1):295–301. doi: 10.1042/bj3030295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Veale D., Yanni G., Rogers S., Barnes L., Bresnihan B., Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum. 1993 Jul;36(7):893–900. doi: 10.1002/art.1780360705. [DOI] [PubMed] [Google Scholar]
  168. Velvart M., Fehr K. Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes. Rheumatol Int. 1987;7(5):195–202. doi: 10.1007/BF00541377. [DOI] [PubMed] [Google Scholar]
  169. Vincent F., Corral M., Defer N., Adolphe M. Effects of oxygen free radicals on articular chondrocytes in culture: c-myc and c-Ha-ras messenger RNAs and proliferation kinetics. Exp Cell Res. 1991 Feb;192(2):333–339. doi: 10.1016/0014-4827(91)90049-z. [DOI] [PubMed] [Google Scholar]
  170. Vincenti M. P., Clark I. M., Brinckerhoff C. E. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum. 1994 Aug;37(8):1115–1126. doi: 10.1002/art.1780370802. [DOI] [PubMed] [Google Scholar]
  171. Vuorio E., de Crombrugghe B. The family of collagen genes. Annu Rev Biochem. 1990;59:837–872. doi: 10.1146/annurev.bi.59.070190.004201. [DOI] [PubMed] [Google Scholar]
  172. Wahl S. M., Allen J. B., Wong H. L., Dougherty S. F., Ellingsworth L. R. Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium. J Immunol. 1990 Oct 15;145(8):2514–2519. [PubMed] [Google Scholar]
  173. Waldmann T. A., Strober W. Metabolism of immunoglobulins. Prog Allergy. 1969;13:1–110. doi: 10.1159/000385919. [DOI] [PubMed] [Google Scholar]
  174. Washko P., Rotrosen D., Levine M. Ascorbic acid transport and accumulation in human neutrophils. J Biol Chem. 1989 Nov 15;264(32):18996–19002. [PubMed] [Google Scholar]
  175. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  176. Wiesenberg I., Van der Meide P. H., Schellekens H., Alkan S. Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin Exp Immunol. 1989 Nov;78(2):245–249. [PMC free article] [PubMed] [Google Scholar]
  177. Wilkinson L. S., Edwards J. C., Poston R. N., Haskard D. O. Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest. 1993 Jan;68(1):82–88. [PubMed] [Google Scholar]
  178. Wilkinson L. S., Pitsillides A. A., Worrall J. G., Edwards J. C. Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). Arthritis Rheum. 1992 Oct;35(10):1179–1184. doi: 10.1002/art.1780351010. [DOI] [PubMed] [Google Scholar]
  179. Wilkinson L. S., Worrall J. G., Sinclair H. D., Edwards J. C. Immunohistological reassessment of accessory cell populations in normal and diseased human synovium. Br J Rheumatol. 1990 Aug;29(4):259–263. doi: 10.1093/rheumatology/29.4.259. [DOI] [PubMed] [Google Scholar]
  180. Williams R. O., Feldmann M., Maini R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9784–9788. doi: 10.1073/pnas.89.20.9784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Williams R. O., Feldmann M., Maini R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9784–9788. doi: 10.1073/pnas.89.20.9784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Wilson K. P., Black J. A., Thomson J. A., Kim E. E., Griffith J. P., Navia M. A., Murcko M. A., Chambers S. P., Aldape R. A., Raybuck S. A. Structure and mechanism of interleukin-1 beta converting enzyme. Nature. 1994 Jul 28;370(6487):270–275. doi: 10.1038/370270a0. [DOI] [PubMed] [Google Scholar]
  183. Winchester R., Su F., Ritchlin C. Alteration of synoviocytes by inflammation--the source of a persistent non-immunologic drive in synovitis: analysis of levels of mRNA expression by a simple multi-gene assay. Clin Exp Rheumatol. 1993 Mar-Apr;11 (Suppl 8):S87–S90. [PubMed] [Google Scholar]
  184. Winyard P. G., Pall H., Lunec J., Blake D. R. Non-caeruloplasmin-bound copper ('phenanthroline copper') is not detectable in fresh serum or synovial fluid from patients with rheumatoid arthritis. Biochem J. 1987 Oct 1;247(1):245–246. doi: 10.1042/bj2470245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Winyard P. G., Tatzber F., Esterbauer H., Kus M. L., Blake D. R., Morris C. J. Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis. 1993 Sep;52(9):677–680. doi: 10.1136/ard.52.9.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Woolley D. E., Crossley M. J., Evanson J. M. Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum. 1977 Jul-Aug;20(6):1231–1239. doi: 10.1002/art.1780200612. [DOI] [PubMed] [Google Scholar]
  187. Yanni G., Whelan A., Feighery C., Bresnihan B. Analysis of cell populations in rheumatoid arthritis synovial tissues. Semin Arthritis Rheum. 1992 Jun;21(6):393–399. doi: 10.1016/0049-0172(92)90040-k. [DOI] [PubMed] [Google Scholar]
  188. Yanni G., Whelan A., Feighery C., Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis. 1994 Jan;53(1):39–44. doi: 10.1136/ard.53.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Yanni G., Whelan A., Feighery C., Quinlan W., Symons J., Duff G., Bresnihan B. Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration. Clin Exp Immunol. 1993 Sep;93(3):387–395. doi: 10.1111/j.1365-2249.1993.tb08190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Zimmerman R. J., Chan A., Leadon S. A. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res. 1989 Apr 1;49(7):1644–1648. [PubMed] [Google Scholar]
  191. Zvaifler N. J., Firestein G. S. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum. 1994 Jun;37(6):783–789. doi: 10.1002/art.1780370601. [DOI] [PubMed] [Google Scholar]
  192. Zvaifler N. J., Firestein G. S. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum. 1994 Jun;37(6):783–789. doi: 10.1002/art.1780370601. [DOI] [PubMed] [Google Scholar]
  193. van de Loo F. A., Arntz O. J., Otterness I. G., van den Berg W. B. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol. 1992 Mar;19(3):348–356. [PubMed] [Google Scholar]
  194. van der Vliet A., O'Neill C. A., Halliwell B., Cross C. E., Kaur H. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite. FEBS Lett. 1994 Feb 14;339(1-2):89–92. doi: 10.1016/0014-5793(94)80391-9. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES